Herpes simplex virus type 1 and Bell's palsy—a current assessment of the controversy

References

• Baringer JR. (1974). Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med 291:828–830.
   PubMed Web of Science ®Google Scholar
• Baringer JR, Swoveland P. (1973). Recovery of herpes simplex virus from human trigeminal ganglions. N Engl J Med 288:648–650.
   PubMed Web of Science ®Google Scholar
• Bastian FO, Rabson AS, Yee CL. (1972). Herpesvirus hominis: isolation from human trigeminal ganglion. Science 178:306–307.
   PubMed Web of Science ®Google Scholar
• Davenport RJ, Sullivan F, Smith B, Morrison J, McKinstry B. (2008). Treatment for Bell's palsy. Lancet 372:1219–1220.
   Google Scholar
• De Almeida JR, Al Khabori M, Guyatt GH, Witterick IJ, Lin VYW, Nedzelski JM, Chen JM. (2009). Combined corticosteroid and antiviral treatment for Bell palsy. A systematic review and meta-analysis. JAMA 302:985–993.
   PubMed Web of Science ®Google Scholar
• Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkaranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L. (2008). Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet (Neurol) 7:993–1000.
   PubMed Web of Science ®Google Scholar
• Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkaranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L. (2009). Is antiviral medication for severe Bell's palsy still useful? Authors' reply. Lancet (Neurol) 8:509–510.
   Google Scholar
• Furuta Y, Takasu T, Sato KC, Fukuda S, Inuyama Y, Nagashima K. (1992). Latent herpes simplex virus type 1 in human geniculate ganglia. Acta Neuropathol 84:39–44.
   PubMed Web of Science ®Google Scholar
• Gilden D. (2008). Treatment of Bell's palsy—the pendulum has swung back to steroids alone. Lancet (Neurol) 7:976–977.
   Google Scholar
• Gilden DH, Tyler KL. (2007). Bell's palsy—is glucocorticoid treatment enough? N Engl J Med 357:1653–1655.
   Google Scholar
• Gilden DH, Wright RR, Schneck SA, Gwaltney JM Jr, Mahalingam R. (1994). Zoster sine herpete, a clinical variant. Ann Neurol 35:530–533.
   PubMedGoogle Scholar
• Hato N, Murakami S, Gyo K. (2008). Steroid and antiviral treatment for Bell's palsy. Lancet 371:1818–1820.
   PubMed Web of Science ®Google Scholar
• Hato N, Yamada H, Kohno H, Matsumoto S, Honda N, Gyo K, Fukuda S, Furuta Y, Ohtani F, Aizawa H, Aoyagi M, Inamura H, Nakashima T, Nakata S, Murakami S, Kiguchi J, Yamano K, Takeda T, Hamada M, Yamakawa K. (2007). Valacyclovir and Prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol 28:408–413.
   PubMed Web of Science ®Google Scholar
• Kawaguchi K, Inamura H, Abe Y, Koshu H, Takashita E, Muraki Y, Matsuzaki Y, Nishimura H, Ishikawa H, Fukao A, Hongo S, Aoyagi M. (2006). Reactivation of herpes simplex virus type-1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and Valacyclovir in patients with Bell's palsy. Laryngoscope 117:147–156.
   Google Scholar
• Kennedy PGE, Al-Saadi SA, Clements GB. (1983). Reactivation of latent herpes simplex virus from dissociated identified dorsal root ganglion cells in culture. J Gen Virol 64:1629–1635.
   PubMed Web of Science ®Google Scholar
• Lockhart P, Daly F, Pitkethly M, Comerford N, Sullivan F. (2008). Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev (4): Art. No.: CD001869. DOI: 10.1002/14651858.CD001869.pub4.
   Google Scholar
• Mitchell BM, Bloom DC, Cohrs RJ, Gilden DH, Kennedy PGE. (2003). Herpes simplex virus-1 and varicella-zoster virus latency in ganglia. J NeuroVirol 9:194–204.
   PubMed Web of Science ®Google Scholar
• Murakami S, Mizobuchi M, Nakashiro Y, Doi T, Hato N, Yanagihara N. (1996). Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 124:27–30.
   PubMed Web of Science ®Google Scholar
• Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK, Peleg AY. (2009). The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ 339:1–7.
   Google Scholar
• Schultz P, Arbusow V, Strupp M, Dieterich M, Rauch E, Brandt T. (1998). Highly variable distribution of HSV-1 specific DNA in human geniculate, vestibular and spiral ganglia. Neurosci Lett 14:139–142.
   Google Scholar
• Steiner I, Kennedy PGE. (1995). Herpes simplex virus latent infection in the nervous system. J NeuroVirol 1:19–29.
   PubMed Web of Science ®Google Scholar
• Steiner I, Spivack JG, Lirette RP, Brown SM, MacLean AR, Subak-Sharpe JH, Fraser NW. (1989). Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J 8:505–511.
   PubMed Web of Science ®Google Scholar
• Sullivan F, Swan I, Daly F. (2008). Prednisolone or acyclovir in Bell's palsy. Authors' Reply. N Engl J Med 358:307.
   Google Scholar
• Sullivan FM, Swan IRC, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, Hayavi S, McAteer A, Stewart K, Daly F. (2007). Early treatment with prednisolone or acyclovir in Bell's palsy. New Engl J Med 357:1598–1606.
   PubMed Web of Science ®Google Scholar
• Thompson RL, Sawtell NM. (2001). Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J Virol, 75:6660–6675.
   PubMed Web of Science ®Google Scholar
• Takasu T, Furuta Y, Sato KC, Fukuda S, Inuyama Y, Nagashima K. (1992). Detection of latent herpes simplex virus DNA and RNA in human geniculate ganglia by the polymerase chain reaction. Acta Otolaryngol 112(6):1004–1011.
   Google Scholar
• Wakisaka H, Hato N, Honda N, Takahashi H, Kisaki H, Murakami S, Gyo K, Mominoki K, Kobayashi N, Matsuda S. (2002). Demyelination associated with HSV-1-induced facial paralysis. Exp Neurol 178:68–79.
   Google Scholar
• Warren KG, Devlin M, Gilden DH, Wroblewska Z, Koprowski H, Brown SM, Subak-Sharpe J. (1978) Herpes simplex virus latency in patients with multiple sclerosis, lymphoma and normal humans. In: Oncogenesis and herpesvirus III, part 2: cell-virus interactions, host response to herpesvirus infection and associated tumors, role of co-factors. de-The G, Henle W, Rapp R (eds). Lyon, France: International Agency for Research on Cancer, pp 765–768.
   Google Scholar